Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.22%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +34.95%
#5 Humanity Humanity +26.29%
#6 Codatta Codatta +19.83%
#7 Walrus Walrus +18.24%
#8 Enso Enso +17.51%
#9 RedStone RedStone +16.76%
#10 Collector Crypt Collector Crypt +14.50%
Coin of the day
EXOD EXOD
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
ISR Immune System Regulation Holding AB (publ) ISR Immune System Regulation Holding AB (publ)

ISR Immune System Regulation Holding AB (publ)

ISR
Classement en actions #36417
ISR Immune System Regulation Holding AB (publ), headquartered in Stockholm,... ISR Immune System Regulation Holding AB (publ), headquartered in Stockholm, Sweden, is dedicated to the discovery and development of pharmaceutical solutions for viral infections. Its current therapeutic pipeline features a Covid-19 vaccine candidate, treatments for Hepatitis B (HBV) and HIV, and an oncology program.
Prix de l'action
$0.13174785
Dernière synchronisation: 2023-05-23
Capitalisation boursière
$2.71M
Changement (1 jour)
-0.61%
Changement (1 an)
0.00%
Pays
SE
Échange ISR Immune System Regulation Holding AB (publ) (ISR)

Catégorie

Healthcare
Ratio P/B pour ISR Immune System Regulation Holding AB (publ) (ISR)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de ISR Immune System Regulation Holding AB (publ), le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour ISR Immune System Regulation Holding AB (publ) de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE